Hinge Health, Inc.

  • Market Cap: Small Cap
  • Industry: Electronics & Appliances
  • ISIN: US4333131039
USD
43.67
3.02 (7.43%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

350.74 k

Shareholding (Dec 2025)

FII

11.66%

Held by 54 FIIs

DII

34.54%

Held by 25 DIIs

Promoter

33.12%

Is Hinge Health, Inc. technically bullish or bearish?

28-Oct-2025

As of October 24, 2025, Hinge Health, Inc. shows a mildly bearish trend, supported by key indicators like Bollinger Bands and On-Balance Volume, with recent performance underperforming the S&P 500.

As of 24 October 2025, the technical trend for Hinge Health, Inc. has changed from sideways to mildly bearish. Key indicators supporting this stance include the weekly Bollinger Bands, Dow Theory, and On-Balance Volume (OBV), all indicating a mildly bearish outlook. The MACD and RSI show no signals on both weekly and monthly time frames, suggesting a lack of momentum. In terms of performance, the stock has underperformed the S&P 500 over the past week and month, with returns of 0.65% and -8.54% respectively, compared to the S&P 500's returns of 1.92% and 2.32%.

View full answer
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Electronics & Appliances

stock-summary
Market cap

USD 3,252 Million (Small Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.95

stock-summary
Return on Equity

-999,999.00%

stock-summary
Price to Book

8.59

Revenue and Profits:
Net Sales:
171 Million
(Quarterly Results - Dec 2025)
Net Profit:
31 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.75%
0%
-12.75%
6 Months
-20.8%
0%
-20.8%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Hinge Health, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
41.70%
EBIT Growth (5y)
-247.87%
EBIT to Interest (avg)
0
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
10.76
EV to EBIT
-6.60
EV to EBITDA
-6.64
EV to Capital Employed
-101.61
EV to Sales
7.51
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-113.37%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
Bollinger Bands
Mildly Bearish
KST
Dow Theory
Mildly Bullish
Bearish
OBV
Bullish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Strategic Entities

Domestic Funds

Held in 29 Schemes (20.68%)

Foreign Institutions

Held by 54 Foreign Institutions (11.66%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 10.70% vs 10.86% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 1,827.78% vs 99.69% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "170.70",
          "val2": "154.20",
          "chgp": "10.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "28.50",
          "val2": "-3.70",
          "chgp": "870.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-1.20",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "31.10",
          "val2": "-1.80",
          "chgp": "1,827.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "159.60%",
          "val2": "-31.90%",
          "chgp": "19.15%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 50.59% vs 33.38% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -3,463.87% vs 88.99% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "587.90",
          "val2": "390.40",
          "chgp": "50.59%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-541.20",
          "val2": "-18.50",
          "chgp": "-2,825.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-7.50",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-424.10",
          "val2": "-11.90",
          "chgp": "-3,463.87%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-929.40%",
          "val2": "-62.60%",
          "chgp": "-86.68%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
170.70
154.20
10.70%
Operating Profit (PBDIT) excl Other Income
28.50
-3.70
870.27%
Interest
0.00
0.00
Exceptional Items
0.00
-1.20
100.00%
Consolidate Net Profit
31.10
-1.80
1,827.78%
Operating Profit Margin (Excl OI)
159.60%
-31.90%
19.15%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is 10.70% vs 10.86% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is 1,827.78% vs 99.69% in Sep 2025

Annual Results Snapshot (Consolidated) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
587.90
390.40
50.59%
Operating Profit (PBDIT) excl Other Income
-541.20
-18.50
-2,825.41%
Interest
0.00
0.00
Exceptional Items
0.00
-7.50
100.00%
Consolidate Net Profit
-424.10
-11.90
-3,463.87%
Operating Profit Margin (Excl OI)
-929.40%
-62.60%
-86.68%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2025 is 50.59% vs 33.38% in Dec 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -3,463.87% vs 88.99% in Dec 2024

stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details